F2RL1 and metabolic syndrome: Studies show PAR2-mediated endothelium-dependent relaxations are often preserved when endothelial cell responses elicited by other GPCR agonists, such as acetylcholine (ACh) and bradykinin, are reduced in animal models of disease, including hypertension, stroke, diabetes, obesity, and metabolic syndrome [40,41,42].